{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:50:59Z","timestamp":1767703859807,"version":"3.41.2"},"reference-count":27,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2022,5,1]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Various studies have shown a number of glycemic parameters to improve over several weeks in people with type 1 diabetes during the first surge of the COVID-19 pandemic. Whether and to what extent such improvement is sustained during following COVID-19 surges remains unknown. Therefore, the aim of this study was to investigate glycemic parameters during the first year of the COVID-19 pandemic in people with type 1 diabetes and to determine factors associated with glycemic improvement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>This was an observational cohort study in people with type 1 diabetes, aged \u226516 years. We compared glycated hemoglobin (HbA<jats:sub>1c<\/jats:sub>) and flash glucose monitoring (FGM) downloads between the prelockdown period and approximately 1 year thereafter. Using logistic regression analysis, we assessed associations between an HbA<jats:sub>1c<\/jats:sub> reduction of at least 0.5% (~5.5 mmol\/mol) with baseline clinical characteristics and self-reported changes in psychological well-being and lifestyle behavior related to COVID-19.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 437 participants were included. As compared with prepandemic data, 1 year after the start of the COVID-19 pandemic and associated lockdowns, HbA<jats:sub>1c<\/jats:sub> had decreased from 7.9%\u00b11.1% (63\u00b112 mmol\/mol) to 7.5%\u00b11.0% (59\u00b111 mmol\/mol) (p&lt;0.001), whereas time in range increased from 55.8%\u00b116.7% to 58.6%\u00b116.7% (p=0.004) and time below (&lt;3.9 mmol\/L) and above (&gt;13.9 mmol\/L) range and glucose variability all decreased (all p&lt;0.05). FGM use, higher HbA<jats:sub>1c<\/jats:sub> at baseline and current smoking were independently associated with an HbA<jats:sub>1c<\/jats:sub> decrease of at least 0.5%, whereas self-reported changes in psychological well-being and lifestyle behavior related to the first surge of the COVID-19 pandemic and associated lockdowns were not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The COVID-19 pandemic and related lockdown measures were associated with improvement in glucometrics, including HbA<jats:sub>1c<\/jats:sub> and FGM data, in individuals with type 1 diabetes, particularly in FGM users, those with higher HbA<jats:sub>1c<\/jats:sub> at baseline or current smokers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2022-002789","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:41:03Z","timestamp":1653291663000},"page":"e002789","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-7820","authenticated-orcid":false,"given":"Namam","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumia","family":"El Hamdaoui","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giesje","family":"Nefs","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Radboudumc Radboud Institute for Health Sciences, Nijmegen, The Netherlands"},{"name":"Center of Research on Psychological disorders and Somatic diseases (CoRPS), Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands"},{"name":"Diabeter, National Treatment and Research Center for Children, Adolescents and Adults with Type 1 Diabetes, Rotterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-1653","authenticated-orcid":false,"given":"Cornelis J","family":"Tack","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1255-7741","authenticated-orcid":false,"given":"Bastiaan E","family":"De Galan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Radboud University Nijmegen, Nijmegen, The Netherlands"},{"name":"Internal Medicine\/Endocrinology, Maastricht University Medical Centre+, Maastricht, The Netherlands"},{"name":"CARIM School for Cardiovascular Disease, Maastricht University, Maastricht, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"2025073111483459000_10.3.e002789.1","unstructured":"WHO . Who coronavirus (COVID-19) Dashboard, 2021. Available: https:\/\/covid19.who.int\/ [Accessed 01 Jan 2022]."},{"key":"2025073111483459000_10.3.e002789.2","doi-asserted-by":"crossref","first-page":"e936","DOI":"10.1210\/clinem\/dgaa825","article-title":"COVID-19 hospitalization in adults with type 1 diabetes: results from the T1D exchange multicenter surveillance study","volume":"106","author":"O'Malley","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073111483459000_10.3.e002789.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.02.009"},{"key":"2025073111483459000_10.3.e002789.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"2025073111483459000_10.3.e002789.5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"2025073111483459000_10.3.e002789.6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s13410-020-00868-7","article-title":"Impact of glycemic control in diabetes mellitus on management of COVID-19 infection","author":"Bhandari","year":"2020","journal-title":"Int J Diabetes Dev Ctries"},{"key":"2025073111483459000_10.3.e002789.7","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00125-021-05463-x","article-title":"A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection","volume":"64","author":"Ruan","year":"2021","journal-title":"Diabetologia"},{"key":"2025073111483459000_10.3.e002789.8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/1932296820929381","article-title":"Would you believe? A virus changes diabetes care","volume":"14","author":"Tack","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2025073111483459000_10.3.e002789.9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/1932296820930270","article-title":"Relative limited impact of COVID-19 on diabetes: a personal view","volume":"14","author":"de Galan","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2025073111483459000_10.3.e002789.10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5694\/mja2.50665","article-title":"Challenges of diabetes management during the COVID-19 pandemic","volume":"213","author":"Scott","year":"2020","journal-title":"Med J Aust"},{"key":"2025073111483459000_10.3.e002789.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-002035"},{"key":"2025073111483459000_10.3.e002789.12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s13300-020-00829-7","article-title":"Glycaemic control among people with type 1 diabetes during Lockdown for the SARS-CoV-2 outbreak in Italy","volume":"11","author":"Bonora","year":"2020","journal-title":"Diabetes Ther"},{"key":"2025073111483459000_10.3.e002789.13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00592-020-01614-5","article-title":"Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England","volume":"58","author":"Prabhu Navis","year":"2021","journal-title":"Acta Diabetol"},{"key":"2025073111483459000_10.3.e002789.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108354"},{"key":"2025073111483459000_10.3.e002789.15","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14374","article-title":"Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring","volume":"38","author":"Dover","year":"2021","journal-title":"Diabet Med"},{"key":"2025073111483459000_10.3.e002789.16","doi-asserted-by":"crossref","first-page":"bvaa149","DOI":"10.1210\/jendso\/bvaa149","article-title":"Impact of COVID-19 Lockdown on glycemic control in adults with type 1 diabetes mellitus","volume":"4","author":"Pla","year":"2020","journal-title":"J Endocr Soc"},{"key":"2025073111483459000_10.3.e002789.17","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12261"},{"key":"2025073111483459000_10.3.e002789.18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.4.517"},{"key":"2025073111483459000_10.3.e002789.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1559-5"},{"key":"2025073111483459000_10.3.e002789.20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dsx.2020.07.016","article-title":"Impact of lockdown in COVID 19 on glycemic control in patients with type 1 diabetes mellitus","volume":"14","author":"Verma","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2025073111483459000_10.3.e002789.21","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13980","article-title":"Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management","volume":"75","author":"Holland","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2025073111483459000_10.3.e002789.22","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108750","article-title":"Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy","volume":"174","author":"Falcetta","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073111483459000_10.3.e002789.23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13300-019-00720-0","article-title":"The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies","volume":"11","author":"Evans","year":"2020","journal-title":"Diabetes Ther"},{"key":"2025073111483459000_10.3.e002789.24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2017.12.015","article-title":"Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests","volume":"137","author":"Dunn","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073111483459000_10.3.e002789.25","doi-asserted-by":"publisher","DOI":"10.1111\/dme.l4319"},{"key":"2025073111483459000_10.3.e002789.26","doi-asserted-by":"crossref","first-page":"e14665","DOI":"10.1111\/dme.14665","article-title":"What people with diabetes in Denmark worry about during the COVID-19 pandemic: a longitudinal study of the first 3 months of the COVID-19 pandemic","volume":"38","author":"Joensen","year":"2021","journal-title":"Diabet Med"},{"key":"2025073111483459000_10.3.e002789.27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00125-021-05578-1","article-title":"Flash monitor initiation is associated with improvements in HbA\n                  1c\n                levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study","volume":"65","author":"Jeyam","year":"2022","journal-title":"Diabetologia"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2022-002789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:48:44Z","timestamp":1753987724000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2022-002789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,5,20]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/bmjdrc-2022-002789"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2022-002789","relation":{},"ISSN":["2052-4897"],"issn-type":[{"type":"electronic","value":"2052-4897"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}